trauma screw
-
Extremities
The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement
TAMPERE, Finland, Nov. 20, 2024 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, is moving ahead with…
Read More » -
Financial
Bioretec Ltd’s half-year report January-June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results
TAMPERE, Finland, Aug. 15, 2024 /PRNewswire/ — This announcement is a summary of Bioretec Ltd’s half-year report January-June 2024. The complete half-year report…
Read More » -
Extremities
Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures
TAMPERE, Finland, June 19, 2024 /PRNewswire/ — Bioretec Ltd., a pioneer in biodegradable orthopedic implants, is pleased to announce that a number of…
Read More » -
Regulatory
Bioretec updates its estimate of the timing for approval of the CE mark for the RemeOs™ trauma screw
TAMPERE, Finland, Nov. 4, 2022 /PRNewswire/ — Bioretec Ltd, a pioneer in biodegradable orthopedic implants, expects the European marketing authorization for the RemeOs™…
Read More »